These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16316482)

  • 41. A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder.
    Bielski RJ; Bose A; Chang CC
    Ann Clin Psychiatry; 2005; 17(2):65-9. PubMed ID: 16075658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
    Li H; Li T; Li G; Luo J
    Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study.
    Stein DJ; Ahokas A; Márquez MS; Höschl C; Oh KS; Jarema M; Avedisova AS; Albarran C; Olivier V
    J Clin Psychiatry; 2014 Apr; 75(4):362-8. PubMed ID: 24569045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
    Coric V; Feldman HH; Oren DA; Shekhar A; Pultz J; Dockens RC; Wu X; Gentile KA; Huang SP; Emison E; Delmonte T; D'Souza BB; Zimbroff DL; Grebb JA; Goddard AW; Stock EG
    Depress Anxiety; 2010 May; 27(5):417-25. PubMed ID: 20455246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anxiety symptom severity and functional recovery or relapse.
    Stein DJ; Bandelow B; Dolberg OT; Andersen HF; Baldwin DS
    Ann Clin Psychiatry; 2009; 21(2):81-8. PubMed ID: 19439157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
    Olié JP; Tonnoir B; Ménard F; Galinowski A
    Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder.
    Strawn JR; Moldauer L; Hahn RD; Wise A; Bertzos K; Eisenberg B; Greenberg E; Liu C; Gopalkrishnan M; McVoy M; Knutson JA
    J Child Adolesc Psychopharmacol; 2023 Apr; 33(3):91-100. PubMed ID: 37074330
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
    Montgomery S; Emir B; Haswell H; Prieto R
    Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensions.
    Stein DJ; Andersen EW; Lader M
    Eur Neuropsychopharmacol; 2006 Jan; 16(1):33-8. PubMed ID: 16014329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Escitalopram versus placebo in the treatment of dysthymic disorder.
    Hellerstein DJ; Batchelder ST; Hyler S; Arnaout B; Toba C; Benga I; Gangure D
    Int Clin Psychopharmacol; 2010 May; 25(3):143-8. PubMed ID: 21811192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Escitalopram.
    Burke WJ
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1477-86. PubMed ID: 12387707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder.
    Schmitt L; Tonnoir B; Arbus C
    Neuropsychobiology; 2006; 54(4):201-7. PubMed ID: 17337913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of comorbid anxiety and depression with escitalopram: results of a post-marketing surveillance study.
    Laux G; Friede M; Müller WE
    Pharmacopsychiatry; 2013 Jan; 46(1):16-22. PubMed ID: 22648305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of escitalopram and paroxetine in the treatment of major depressive disorder.
    Lin HL; Hsu YT; Liu CY; Chen CH; Hsiao MC; Liu YL; Shen WW; Hsiao CF; Liu SI; Chang LH; Tang HS; Lai HL; Lin PS; Lin KM; Tsou HH
    Int Clin Psychopharmacol; 2013 Nov; 28(6):339-45. PubMed ID: 23881184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes.
    Stein DJ; Andersen HF; Goodman WK
    Ann Clin Psychiatry; 2005; 17(2):71-5. PubMed ID: 16075659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study.
    Stein DJ; Ahokas A; Albarran C; Olivier V; Allgulander C
    J Clin Psychiatry; 2012 Jul; 73(7):1002-8. PubMed ID: 22901350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Escitalopram: a review of its use in the management of anxiety disorders.
    Dhillon S; Scott LJ; Plosker GL
    CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults.
    Wetherell JL; Petkus AJ; White KS; Nguyen H; Kornblith S; Andreescu C; Zisook S; Lenze EJ
    Am J Psychiatry; 2013 Jul; 170(7):782-9. PubMed ID: 23680817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
    Mao JJ; Xie SX; Keefe JR; Soeller I; Li QS; Amsterdam JD
    Phytomedicine; 2016 Dec; 23(14):1735-1742. PubMed ID: 27912875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of vortioxetine in working patients with generalized anxiety disorder.
    Christensen MC; Loft H; Florea I; McIntyre RS
    CNS Spectr; 2019 Apr; 24(2):249-257. PubMed ID: 29081307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.